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Mutants of minute virus of mice (MVM) which express truncated forms of the NS2 polypeptide are known to exhibit a
host range defect, replicating productively in transformed human cells but not in cells from their normal murine host. To
explore this deficiency we generated viruses with translation termination codons at various positions in the second exon
of NS2. In human cells these mutants were viable, but showed a late defect in progeny virion release which put them at a
selective disadvantage compared to the wildtype. In murine cells, however, duplex viral DNA amplification was reduced to
5% of wildtype levels and single-strand DNA synthesis was undetectable. These deficiencies could not be attributed to a
failure to initiate infection or to a generalized defect in viral gene expression, since the viral replicator protein NS1 was
expressed to normal or elevated levels early in infection. In contrast, truncated NS2 gene products failed to accumulate,
so that each mutant exhibited a similar NS2-null phenotype. Expression of the capsid polypeptides VP1 and VP2 and their
subsequent assembly into intact particles were examined in detail. Synchronized infected cell populations labeled under
pulse–chase conditions were analyzed by differential immunoprecipitation of native or denatured extracts using antibodies
which discriminated between intact particles and isolated polypeptide chains. These analyses showed that at early times
in infection, capsid protein synthesis and stability were normal, but particle assembly was impaired. Unassembled VP
proteins were retained in the cell for several hours, but as the unprocessed material accumulated, capsid protein synthesis
progressively diminished, so that at later times relatively few VP molecules were synthesized. Thus in NS2-null infections
of mouse cells there is a major primary defect in the folding or assembly processes required for effective capsid production.
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INTRODUCTION more uniform distribution (Clemens et al., 1990; Cotmore
and Tattersall, 1990). Although both NS1 and NS2 are
Parvoviruses encode two separate gene complexes,
synthesized from the same promoter (P4) early in S-
with transcripts from one half of their small (5-kb) linear
phase, NS2 polypeptides accumulate approximately
DNA genome programming the synthesis of an overlap- three times as fast as NS1, making them the predominant
ping set of capsid polypeptides, while the other half gives virally coded protein in the cell at this time. Since the
rise to nonstructural proteins involved in DNA replication. half-life of all subtypes is relatively short (1 hr), NS2
The murine virus MVM encodes two types of nonstructu- accumulation peaks early in infection but rapidly dimin-
ral proteins; an 83-kDa nuclear phosphoprotein, NS1, ishes thereafter as the activity of the P4 promoter de-
which is a site-specific DNA-binding protein essential for clines (Clemens and Pintel, 1988; Cotmore and Tattersall,
many aspects of viral DNA replication, transcriptional 1990).
regulation, and modulation of the cellular environment, Although not essential for productive infection in a
and three distinct forms of a 25-kDa NS2 polypeptide variety of nonmurine cell lines in culture, NS2 is abso-
(Cotmore and Tattersall, 1987, 1995). NS2 subtypes all lutely required in cells from its natural host species both
share a central exon of 98 amino acids and have an 84- in culture and in the whole animal (Naeger et al., 1990;
amino-acid N-terminal domain in common with NS1, but Brownstein et al., 1992; Cater and Pintel, 1992; Naeger
they differ from each other in having unique carboxy- et al., 1993). MVM mutants which do not encode full-
terminal peptides, 6–13 amino acids long (Cotmore and length NS2 polypeptides have been reported to exhibit
Tattersall, 1986, 1990; Jongeneel et al., 1986; Morgan and multiple, diverse DNA replication defects in mouse cells
Ward, 1986). Each NS2 subtype exists in approximately and to accumulate reduced levels of the viral capsid
equal numbers of phosphorylated and nonphosphory- polypeptides (Naeger et al., 1990, 1993). Although bio-
lated forms and while the former are totally excluded chemical analyses have so far failed to yield any informa-
from the nucleus, the nonphosphorylated forms show a tion concerning the specific function(s) of NS2 molecules,
their high-level expression early in infection suggests
that they are unlikely to be purely catalytic or regulatory† Deceased.
and may well perform multiple roles in the viral life cycle.1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (203) 785-7340. E-mail: Peter_Tattersall@QM.Yale.edu. A similar species-specific host range defect in viral DNA
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replication has been reported for NS20 mutants of the mutation at nucleotide 2129, which changes an arginine
(AGA) codon at residue 132 in NS2 to the opal terminationclosely related H1 parvovirus (Li and Rhode, 1991), but
in these mutants the expression of all viral proteins was codon TGA.
reduced, and experiments with reporter-gene constructs
Cells and viral stockssuggested that a sequence present in the 3* untranslated
region of all viral mRNAs might render them susceptible The prototype strain MVMp and its mutant derivatives
to translational modulation by NS2 (Li and Rhode, 1993). were propagated in the SV40-transformed newborn hu-
Similar widespread defects in viral protein accumulation man kidney cell line 324K (Tattersall and Bratton, 1983),
were not apparent in the MVM NS2 mutants studied in Dulbecco’s modified Eagle’s minimal medium con-
previously (Naeger et al., 1990, 1993), and in this report taining 5% fetal calf serum. Viruses were initially recov-
we analyze the phenotypes of a new set of MVM NS2 ered from infectious plasmids by Lipofectin (Gibco/BRL) -
mutants and similarly fail to find any evidence for a gener- mediated transfection of 324K monolayers with 5 mg plas-
alized lesion in protein synthesis at early times in infec- mid DNA. First-passage viral stocks were titered on 324K
tion. We have essentially confirmed and redefined the cell monolayers essentially as described previously (Tat-
defects in DNA replication reported earlier and have tersall and Bratton, 1983), except that the time allowed for
used pulse–chase labeling conditions and differential plaque formation was increased to allow for any possible
immunoprecipitation to demonstrate that even the reduc- reduction in the efficiency with which mutant stocks
tion in capsid accumulation associated with this pheno- spread through the culture. These stocks were used to
type at early times in infection is not primarily due to a infect asynchronous cultures of 324K cells or the mouse
reduction in virion protein synthesis per se, but rather L-cell derivative, A9 ouabr11, at 3 PFU per cell unless
reflects an underlying defect in capsid assembly. otherwise stated in the text. Some experiments involved
the use of A9 cell populations synchronized by a double
MATERIALS AND METHODS block schedule described elsewhere (Cotmore and Tat-
tersall, 1987). Briefly, cells were allowed to accumulateConstruction of mutant MVM genomes
in G0 by depriving them of isoleucine for 48 hr, and they
Four NS20 mutant genomes, summarized in Fig. 1, were then allowed to progress to the G1/S boundary by
were constructed in the infectious cloned form of the incubating the cultures in medium containing isoleucine
prototype virus MVMp by site-directed mutagenesis us- and 10 mg/ml of the DNA polymerase a and d inhibitor
ing chimeric polymerase chain reaction (PCR) as pre- aphidicolin, for 20 hr. Viruses were added to the cells
viously described (Nuesch and Tattersall, 1993). along with the aphidicolin and were able to penetrate
NS2-F86am. The serine codon at residue 578 of NS1 the cells and accumulate at an immediately pre-DNA
was changed from TCG to AGC by chimeric PCR. The synthetic step in the viral life cycle prior to removal of
final PCR product was digested with BstEII and XhoI and the inhibitor. All infection times referred to here initiate
used to replace the BstEII (1884) to XhoI (2070) fragment at the point when the aphidicolin was removed and the
of plasmid pMVMp-D1 (Gardiner and Tattersall, 1988). cells became free to transit the S-phase.
While this change conserves the NS1 sequence, it re- Revertant viruses were obtained by plaquing 324K-
places the first codon of the second intron of NS2, which derived stocks on A9 monolayers and amplifying the re-
normally specifies phenylalanine (TTC) at residue 86, vertant plaques in 324K cells. The NS2 exon 2 region of
with the amber termination codon TAG. each genome was then amplified using polymerase
NS2-SA86am. The leucine codon at residue 576 in the chain reaction techniques with viral stocks as template
NS1 gene encoded by pNS2-F86am was changed from and sequenced by the chain termination method using
CTA to CTC using chimeric PCR and by replacement of Sequenase as directed by the supplier (U.S. Biochemi-
the BstEII to XhoI fragment of plasmid pNS2-F86am. This cals, Cleveland, Ohio), essentially as described pre-
mutation destroys the consensus splice acceptor site viously (Ball-Goodrich and Tattersall, 1992).
used in all NS2-encoding transcripts (Naeger et al., 1990;
Li and Rhode, 1991). Detection and analysis of viral DNA
NS2-Q100am. The glutamine codon CAG at residue
To quantitate viral DNA synthesis, asynchronous100 in NS2 was replaced with the amber termination
monolayers of A9 and 324K cells were labeled with 32PO4codon TAG by chimeric PCR. pMVMp-D1 was used as
at 0.5 mCi/ml for 20 hr in Dulbecco’s modified Eagle’stemplate, and the mutation was transferred back into
minimal medium containing 110 of the normal concentra-pMVMp-D1 by replacement of the BstEII to XhoI fragment
as described above. tion of unlabeled phosphate, 5% dialyzed fetal calf serum,
and 100 mg/ml neuraminidase (TypeV, from ClostridiumNS2-R132op. The internal MVM EcoRI fragment (MVM
nts 1084 through 3522) was transferred from plasmid perfringens, obtained from Sigma, St. Louis, MO), in order
to limit replication to a single round by preventing read-pULB3224 (Brandenburger et al., 1990) into EcoRI-di-
gested pMVMp-D1. pULB3224 contains an A to T point sorption of virus to cell receptors. Labeling was started
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FIG. 1. Mutagenesis strategy in the second intron of NS2. (A) The line diagram of the single-stranded MVM genome shows the position of the
nonstructural gene promoter (P4) and the capsid gene promoter (P38). Aligned below this are the three size classes of mRNAs encoded by MVM,
denoted R1 through R3. The stippled box indicates the region which is shown in greater detail in B. (B) DNA sequence between MVMp nucleotides
1961 and 2140, showing the predicted protein coding for this region in open reading frames 2 and 3, used to encode the second exon of NS2 and
part of the body of NS1, respectively. Exon 2 of NS2 initiates at the indicated large intron splice acceptor site. Mutations introduced into this
sequence to create the various NS20 genomes are shown in boxes below the wildtype sequence, and the resulting mutants were named as
described under Materials and Methods.
at 10 hr after infection and terminated with the separate ignated the allotropic determinant, which controls switch-
ing between lymphotropic and fibrotropic phenotypescollection of cells and medium. Total DNA was extracted
(Gardiner and Tattersall, 1988; Ball-Goodrich and Tatter-from each sample and analyzed by electrophoresis
sall, 1992). An additional cysteine residue was addedthrough agarose gels as previously described (Cotmore
at the carboxy-terminus of the peptide to allow efficientand Tattersall, 1992).
conjugation to keyhole limpet hemocyanin, and the con-
jugate was used to raise polyclonal antibodies in rabbitsProduction of specific antisera
according to standard procedures.
Anti-allopeptide serum. A peptide, NH2-QGSRHGTTQ- Anti-VP1-specific serum. Rabbit anti-VP1-specific se-
MGVNWVSK-COOH, which corresponds to the sequence rum was raised against a gel-purified, bacterially ex-
of VP2 between residues 311 and 327 in MVMp, was pressed polypeptide encoding the entire VP1-specific re-
gion of MVM together with a carboxy-terminal (His)6-tag.synthesized. This spans a mutable genetic element, des-
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This antigen will be described in detail elsewhere (S. F. Immunoprecipitation. For immunoprecipitation of total
cell extracts, pellets of approximately 1 1 106 cells wereCotmore, A. M. D’Abramo, and P. Tattersall, manuscript
in preparation). extracted into 0.45 ml of buffer A (0.01 M Tris–HCl, pH 8,
0.15 M NaCl, 0.002 M EDTA, 1% Nonidet P-40) containingAnti-capsid sera. Anti-capsid sera PN1 and PN2 were
derived by repeated immunization of rabbits with 100 0.35% sodium dodecyl sulfate (SDS), and either kept at
room temperature (native samples) or fully denatured byhemagglutination units per injection of cesium chloride
equilibrium gradient-purified empty MVMp particles. heating to 857 for 30 min prior to dilution with buffer A
to a final SDS concentration of 0.25%, and immunoprecip-These sera recognize and neutralize all MVM strains
(Tattersall and Bratton, 1983) and have been used as a itated as previously described (Cotmore and Tattersall,
1986).source of anti-MVM capsid antibodies in studies pub-
lished by our laboratory since 1978. Immunofluorescence. A9 cells were grown, synchro-
nized, and infected with virus on glass spots on Teflon-
Analysis of viral protein synthesis coated slides (Cel-line Associates, Inc., Newfield, NJ).
Western transfer. For Western transfer, cells were har- Cells were released into S-phase in medium containing
vested by scraping into the medium. After centrifugation neuraminidase, to ensure the removal of all noninternal-
the cell pellet was briefly drained and flash-frozen on dry ized virus, and fixed 10 hr later. Cells were permeabilized
ice. For analysis, pellets were solubilized from the frozen and stained as previously described (Cotmore and Tat-
state by rapid boiling in SDS sample buffer and fraction- tersall, 1990), and primary antibodies were detected with
ated by electrophoresis on linear 11–23% gradient gels Texas-red conjugated goat anti-rabbit IgG (Jackson Im-
(Phorcast, Amersham), and blots were probed with rabbit munoResearch Laboratories, Inc., West Grove, PA).
antiserum directed against the amino-terminal peptide
common to both NS1 and NS2 (Cotmore and Tattersall, RESULTS
1986) and detected with 125I-labeled protein A (Amer-
NS20 mutant virus stocks can be generated bysham).
transfection into 324K cellsRadiolabeling of viral proteins. For long-term labeling
of asynchronous cultures, cells were exposed to a [35S]- Full-length infectious plasmid clones of the various
methionine/cysteine labeling mix (Tran35S-label, ICN Ra- wildtype and NS20 mutant genomes were transfected
diochemicals, Irvine, CA) at 20 mCi/ml in Dulbecco’s mod- into A9 and 324K cells, and the cultures were followed
ified Eagle’s minimal medium containing 120 of the normal for cytopathic degeneration and production of viral hem-
concentration of unlabeled methionine and cysteine and agglutinin. As reported in previous studies by Naeger
5% dialyzed fetal calf serum and neuraminidase, starting and colleagues (Naeger et al., 1990, 1993), no virus pro-
10 hr after infection, and the cells were harvested 20 hr duction was observed from repeated transfections of mu-
later. tant plasmids into A9 cells, whereas the wildtype virus
Pulse–chase and pulse-only analyses employed syn- could be recovered readily by transfection into these
chronized A9 populations. In pulse–chase experiments cells. However, mutant virus could be recovered routinely
cells were labeled with 100 mCi/ml Tran35S-label in me- from transfected 324K cells, although the mutant viruses
dium lacking methionine or cysteine for 20 min, starting clearly amplified more slowly than those recovered from
8 hr after release from aphidicolin, and were either har- parallel wildtype MVMp transfections. Initial stocks of
vested 20 min later or transferred into unlabeled medium mutant virus recovered in this way consistently yielded
containing normal levels of methionine and cysteine, and between 1 and 10% of the infectious virus, as measured
harvested, as described above, after indicated chase pe- by the 324K plaque assay, of a wildtype stock prepared
riods. In pulse-only experiments cells were labeled with in parallel. We have measured the particle:infectivity ra-
100 mCi/ml Tran35S-label in medium containing 120 of the tios of these wildtype and NS2
0 mutant virus stocks by
digesting samples with micrococcal nuclease and quan-normal methionine and cysteine concentrations for peri-
ods of 3 hr starting 6, 9, or 12 hr after release from titating the protected DNA by Southern transfer following
alkaline agarose gel electrophoresis. We have generallyaphidicolin, and were harvested, as described above, at
the end of the labeling period. found them to contain equal numbers of viral genomes
per 324K PFU, indicating that the low titers of the mutantsThe labeled wildtype virus used to demonstrate anti-
body specificity was harvested from the medium 30 hr are probably due to inefficient growth rather than a low
intrinsic infectivity. Mutant viruses do require longer toafter the release from aphidicolin of MVMp-infected, syn-
chronized A9 cells. These infected cells were labeled produce visible plaques, and these tend to be much
smaller than those produced by wildtype virus. Occasion-from 6 to 13 hr into S-phase with Tran35S-label, as de-
scribed above for the 3-hr pulses, and then incubated ally discrepancies were observed between numbers of
genomes and 324K PFU, and we believe that this reflectsfrom 13 to 30 hr in normal medium containing 100 mg/
ml neuraminidase, in order to prevent readsorption of the diminished ability of mutant stocks to generate visible
plaques efficiently. Because of this potential variability,virus to cell receptors.
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we have used packaged DNA content, measured by
nuclease treatment combined with alkaline gels as de-
scribed above, to normalize the NS20 mutant stocks rela-
tive to titers determined for the wildtype virus for analyses
of infection at matched multiplicities.
Consistent with their inability to produce virus when
transfected into A9 cells, NS20 mutant virus stocks exhib-
ited about 1005-fold less infectivity in an A9 plaque assay
than in a similar assay carried out in 324K cells. Ex-
panded stocks, however, exhibited intermediate pheno-
types, and we assessed whether this was due to rever-
sion of the original mutation. PCR-mediated direct se-
quencing of several plaques formed on A9 monolayers
infected with NS2-Q100am viral stocks confirmed that
these plaques were produced by viral genomes in which
the amber codon had reverted to a coding triplet. In two
independent revertants the amino acid encoded at posi-
tion 100 in NS2 was tyrosine and in another two it was
glutamic acid. While none of these had reverted the NS2
sequence to wildtype, the glutamic acid change did con-
serve the collinear sequence of NS1, whereas the tyro-
FIG. 2. Western blot analysis of nonstructural protein expressionsine change induced a concomitant conservative change
in the highly synchronized infection of murine A9 cells. Synchronizedin NS1 from serine to threonine. The revertant viruses
uninfected A9 cells (lane 1) and similar cultures infected at 3 PFU/cellappeared to have a considerable growth advantage over
with wildtype virus (lane 2), NS-F86am (lane 3), NS2-Q100am (lane 4),
the mutant, even in 324K cells, and rapidly came to pre- or NS2-R132op were harvested 8 hr after release into S-phase. Blots
dominate in the population upon multiple serial passage. were developed with an antiserum directed against the amino-terminal
peptide common to both NS1 and NS2.Because of this reversion and selection problem, only
early passage stocks of transfection-derived virus were
used in subsequent experiments. structural proteins in these cells 8 hr after their release
The reversion rate of NS2-F86am appeared to be much into S-phase, at a time when both NS1 and NS2 are
lower than that of the other single amino acid substitution normally abundant. At this time cells infected with wild-
mutants, presumably because it is an NS1 serine codon type virus contained approximately equimolar accumula-
replacement which cannot revert to wildtype sequence tions of the two nonstructural proteins, as determined
for both polypeptides in a single step. The low reversion from Western blots developed using an antibody directed
frequency of NS2-F86am made it the mutant of choice against the amino-terminal peptide common to both mol-
for many subsequent analyses. It was also chosen as a ecules (Fig. 2, lane 2). In contrast, neither full-length nor
starting point for the generation of NS2-SA86am, a more truncated forms of NS2 were seen in cells infected with
complex mutant which, lacking a functional splice ac- NS2 translation-termination mutants (Fig. 2, lanes 3–5).
ceptor sequence as well as carrying the F86am mutation, Since the mutant viruses would be expected to synthe-
cannot make the spliced mRNAs needed to encode iso- size NS2 molecules of between 85 and 131 amino acids,
lated copies of the amino-terminal peptide domain com- stable forms of such molecules should be resolved on
mon to both NS1 and NS2. As its design would predict, the 11–23% gradient gel used in this analysis. A small
NS2-SA86am has proven to be the most stable of all of immunoreactive species does appear in all lanes con-
these NS20 mutants. However, in those analyses where taining infected cells, but its apparent molecular weight
it was included, it showed exactly the same phenotype is identical in all viruses, and hence we consider that it
as each of the other second exon NS20 mutants studied. is more likely to be a breakdown product of the highly
abundant NS1 protein than a truncated form of NS2. Thus
the abbreviated NS2 polypeptides encoded by theseTruncated NS2 molecules do not accumulate in
translation-termination mutants do not accumulate in A9mutant virus infections of murine A9 cells
cells, at least to within one or two orders of magnitude
NS2 synthesis peaks early in infection and rapidly di- of wildtype levels, suggesting that they must be much
minishes thereafter (Cotmore and Tattersall, 1990; Scho- less stable and/or synthesized less efficiently. Since all
borg and Pintel, 1991). Since viral infections in A9 cells of these mutants appear to exhibit the same NS2-null
can be efficiently synchronized using a coupled isoleu- phenotype they cannot, as was originally hoped, provide
cine-deprivation/aphidicolin block protocol (Cotmore and information about possible different functions for the N-
and C-terminal domains of NS2.Tattersall, 1987), we analyzed expression of the viral non-
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In marked contrast to NS2 levels, NS1 synthesis was
elevated at this point early in S-phase in the NS20 mutant
infections. NS1 was consistently expressed to higher lev-
els than are seen in the wildtype infection, and this over-
expression correlated inversely with the position of the
termination codon in the NS2 gene. This result was not
surprising since others have shown that the introduction
of termination codons into the second exon of NS2 im-
pedes the splicing required to convert R1 transcripts,
encoding NS1, to R2 transcripts encoding NS2 (Naeger
et al., 1992). Moreover, the level to which splicing was
inhibited in the previous study correlated in a polar fash-
ion with the inverse of the codon position, so that the
earlier the exon was interrupted, the fewer R2 transcripts
were formed and the more NS1-encoding R1 transcripts
remained. While the failure to process R1 transcripts con-
tributes in some part to our inability to detect NS2 gene
products, as seen in Fig. 2, it is probably the major factor
responsible for the relative overexpression of NS1 in
NS20 mutant infections.
Infection of human 324K cells by NS20 mutants is
productive but exhibits a late defect in progeny virion
release
Initially we monitored viral DNA synthesis in 324K cells
by Southern transfer of total cellular and viral DNA, but
the presence of input viral genomes made progeny sin-
gle-stranded synthesis difficult to assess. In order to ob-
tain precise quantitative data on progeny genome pro-
duction and distribution, we used the in vivo 32P-labeling
approach illustrated in Figs. 3A and 3B. Asynchronous
324K cells were infected at 3 PFU per cell and labeled
with [32P]orthophosphate between 10 and 30 hr postin-
fection in the presence of neuraminidase, which served
to restrict infection to a single round. Cells and medium
were then harvested and analyzed separately. Cellular FIG. 3. DNA replication and capsid gene expression in infected hu-
man 324K cells. (A) Autoradiograph of a neutral agarose gel showingDNA replication and viral monomer and dimer duplex
32P-labeled DNA replication products present in cell pellets harvestedreplicative-form (mRF and dRF, respectively) DNA synthe-
from uninfected 324K cells (lane 2) or infected cells 30 hr after thesis appeared similar in cells infected with wildtype and
addition of wildtype MVMp (lane 1) or the NS2 mutant viruses NS2-
mutant viruses (Fig. 3A), although single-stranded prog- Q100am (lane 3), NS2-F86am (lane 4), NS2-R132op (lane 5), or NS2-
eny DNA synthesis appeared somewhat disparate. Cells SA86am (lane 6). Monomeric (mRF) and dimeric (dRF) duplex viral
replication intermediates and progeny single-stranded (ss) DNA areinfected with wildtype virus retained relatively little sin-
indicated. (B) Autoradiograph of a neutral agarose gel showing 32P-gle-stranded DNA at this late time in infection. However,
labeled DNA replication products present in culture supernatants fromsignificant amounts of progeny single-strands were
the 324K monolayers indicated in A, using the same lane designations
found in all mutant-infected cells. This progeny DNA mi- and labeling abbreviations. (C) Autoradiograph of a discontinuous
grated rather diffusely in the gel shown in Fig. 3A, for SDS–PAGE gel showing 35S-labeled capsid proteins (VP1 and VP2)
immunoprecipitated with rabbit anti-capsid serum from combined cellreasons which are not currently understood. However,
pellet and culture supernatant samples from uninfected or infectedwhen extracted under nondisruptive conditions these ge-
324K cells harvested 30 hr after addition of virus. Lane designationsnomes could be immunoprecipitated with anti-capsid
are as for A.
sera and were unit-length and single-stranded when sub-
sequently analyzed by electrophoresis under denaturing
conditions (data not shown). A band of fragmented, par- The retention of single-stranded progeny DNA at this
late time in cells infected with NS20 mutant viruses wastially duplex DNA was also seen in some NS2 mutant-
infected cells, migrating between mRF and single- in marked contrast to the situation in wildtype infections
(compare Figs. 3A and 3B). Although cell degenerationstranded DNA, but the significance of this product is
currently unknown. was still limited at this stage in the infection, as shown
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by the small amount of cellular or RF DNA in the culture
medium (Fig. 3B) relative to that in the cell (Fig. 3A),
most of the progeny wildtype genomes had already been
transported or otherwise released into the medium by
30 hr postinfection (Fig. 3B, lane 1). At the same time,
only 1 to 2% of the NS20 mutant genomes had been
similarly translocated (Fig. 3B, lanes 3–6). While there is
no direct evidence, at present, for a nonlytic mechanism
for progeny virus release, these results clearly show that
it is the release phase, rather than progeny synthesis
per se, which is impaired in NS20 mutant infection of
324K cells.
In parallel we examined the synthesis of capsid pro-
teins in single-round infections of 324K cells with wild-
type and mutant virus under culture conditions compara-
ble to those used in the DNA replication analysis pre-
sented above but using [35S]methionine/cysteine as the
isotopic label. Since single-strand synthesis is concomi-
tant with and dependent upon packaging (reviewed in
Cotmore and Tattersall, 1995), a major reduction in the
availability of capsid proteins at this time could theoreti-
cally reduce and/or retard progeny synthesis. However,
when assessed by immunoprecipitation of pooled cells
and medium under nondenaturing conditions with non-
limiting amounts of the anti-capsid serum PN1, capsid
synthesis appeared essentially identical in 324K cells
infected with wildtype and mutant viruses (Fig. 3C).
Infection of murine A9 cells by NS20 mutants is
abortive for progeny genome synthesis
In order to identify steps in the viral life cycle af-
fected by the NS20 lesion in nonpermissive host cells,
we performed a series of in vivo labeling studies in
asynchronous A9 cells, exactly comparable to those
described above for 324K cells. In marked contrast to FIG. 4. DNA replication and capsid gene expression in infected mu-
rine A9 cells. (A) Autoradiograph of a neutral agarose gel showing 32P-the results from the human cells, in murine A9 cells
labeled DNA replication products present in cell pellets harvested fromincorporation of [32P]orthophosphate into duplex viral
uninfected A9 cells (lane 2) or infected cells 30 hr after the addition ofRF DNA in the mutants was reduced to approximately wildtype MVMp (lane 1) or the NS2 mutant viruses NS2-Q100am (lane
5% of the wildtype level, and single-stranded progeny 3), NS2-F86am (lane 4), NS2-R132op (lane 5), or NS2-SA86am (lane 6).
DNA was undetectable in either cells or medium even Monomeric (mRF) and dimeric (dRF) duplex viral replication intermedi-
ates and progeny single-stranded (ss) DNA are indicated. (B) Autoradio-after prolonged autoradiographic exposure (Figs. 4A
graph of a neutral agarose gel showing 32P-labeled DNA replicationand 4B). Moreover, analysis of capsid protein produc-
products present in culture supernatants from the A9 monolayers indi-tion, assessed by the same PN1 anti-capsid serum cated in A, using the same lane designations and labeling abbrevia-
immunoprecipitation procedure used previously, sug- tions. (C) Autoradiograph of a discontinuous SDS–PAGE gel showing
gested that capsid protein accumulation was severely 35S-labeled capsid proteins (VP1 and VP2) immunoprecipitated with
rabbit anti-capsid serum from combined cell pellet and culture superna-depressed in mutant-infected cells (Fig. 4C). This ap-
tant samples from uninfected or infected A9 cells harvested 30 hr afterparent failure in expression from the P38 promoter has
addition of virus. Lane designations are as for A.been observed previously (Naeger et al., 1993), but is
surprising since NS1 accumulation during the same
20-hr labeling period appeared relatively normal (data close to the normal VP2 start codon in otherwise unal-
tered P38 transcripts and have shown that, even withinnot shown), and transactivation of a capsid-gene pro-
moter-construct was shown to be dependent on NS1 this context, reporter gene expression was similarly
NS2-independent but dependent on NS1 (L. F. Carbo-expression but completely independent of NS2 (Doerig
et al., 1988). We have extended these studies using nell and P. Tattersall, unpublished observations). Thus
it seemed improbable that VP2 expression per seconstructs containing a reporter CAT gene initiating
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expected viral capsid proteins when analyzed by West-
ern transfer (data not shown) or by immunoprecipitation
of [35S]methionine/cysteine-labeled capsid proteins
which have been thoroughly denatured by heating to 857
in 0.375% SDS prior to immunoprecipitation (Fig. 5A,
lanes 3 and 5). Under these conditions the anti-allopep-
tide sera react with both VP1 and VP2 (Fig. 5, lane 5),
while the anti-VP1 sera precipitate only isolated VP1 mol-
FIG. 5. Immunoprecipitation of polypeptides from purified virus with ecules (Fig. 5, lane 3). However, these sera were only
anti-capsid and anti-allopeptide sera. 35S-labeled wildtype MVMp viri-
able to precipitate a small proportion of 35S-labeled intactons were either left intact (lanes 1, 2, 4, 6, and 8) or denatured and
viral particles when such samples were prepared fordissociated into monomer polypeptides by heating to 857 for 30 min in
precipitation without prior heating (Fig. 5A, lanes 2 and0.375% SDS (lanes 3, 5, 7, and 9) before being immunoprecipitated
with anti-capsid serum (lanes 1, 6, and 7), with anti-VP1-specific serum 4). In the experiment shown here the anti-allopeptide
(lanes 2 and 3), or with anti-allopeptide serum (lanes 4 and 5). Unbound serum precipitated approximately 16% of the native 35S-
material from the precipitation of native capsids with anti-capsid serum
labeled capsids present in this population of newly re-shown in lane 6 is shown reprecipitated with anti-VP1-specific serum
leased virus harvested from the medium of synchronizedin lane 8. Unbound material from the precipitation of denatured capsids
MVMp-infected A9 cells, while the anti-VP1 specific se-with anti-capsid serum shown in lane 7 is shown reprecipitated with
anti-VP1-specific serum in lane 9. rum reacted with approximately 7% of such particles.
Since VP2 molecules account for approximately 85% of
capsid polypeptides, five to six VP2 molecules are copre-
would be severely impaired in NS20 mutant infections, cipitated with each VP1 molecule in intact particles.
prompting us to undertake the more detailed analysis
of capsid protein expression described below.
The primary capsid defect in NS20 infection operates
at the level of particle assembly, not capsid proteinAnti-capsid and anti-peptide antibodies differentiate
expression or traffickingbetween mature empty particles and unassembled
VP2 polypeptides
A9 cultures synchronized using the standard double-
block procedure were simultaneously infected with eitherThe polyclonal antisera PN1 and PN2, raised by re-
peated immunization of rabbits with small quantities of wildtype MVMp or NS2-F86am, a particularly stable NS20
mutant virus. Under this regimen cells are released intointact capsids, reacted very efficiently with intact parti-
cles (Fig. 5, lanes 1 and 6), but not with capsids that S-phase 20 hr after infection, so that when the polymer-
ase block is removed, viral genomes are already presenthave been fully disrupted by incubation to 807 or above
(Fig. 5, lane 7). When the unbound material from the latter in the cell nucleus and are able to initiate viral replication
and gene expression rapidly. Eight hours after releaseimmunoprecipitation was reprecipitated with anti-VP1
serum, the remaining VP1 proteins were recovered, into S-phase, at the normal peak of NS2 synthesis, cells
were pulsed with [35S]methionine/cysteine for 20 min andshowing that the conditions used had fully dissociated
them from complexes with VP2 (Fig. 5, lane 9). These two then harvested immediately or transferred back into nor-
mal medium for various chase periods. Immunoprecipita-anti-capsid sera, PN1 and PN2, thus react predominantly
with secondary or higher-order structural determinants tion under native conditions with antiserum PN2, directed
against intact capsids, confirmed the capsid accumula-on the surface of the capsid shell, but poorly with any
of the predominantly linear epitopes presented by fully tion defect reported earlier, with wildtype infections yield-
ing approximately four- to fivefold more precipitable ma-denatured capsid proteins. This finding accords with our
previous observations that these particular sera give very terial than mutant virus infections in both pulse and
pulse–chase samples (Fig. 6A). However, in both wild-poor signals when used to probe Western transfers of
viral capsid proteins (data not shown). type and NS2-F86am infections, samples harvested after
a chase period, rather than immediately after the pulse,In contrast to the anti-capsid sera described above,
anti-allopeptide- and anti-VP1-specific sera react effi- showed a two- to threefold increase in material reacting
with this antibody (Fig. 6A, compare lanes 2 and 5 orciently with isolated VP polypeptides, but very poorly with
intact particles. These sera thus allow discrimination be- lanes 3 and 6). Since we have shown, in the previous
section, that this anti-capsid serum reacts preferentiallytween capsid protein synthesis per se and the processes
required for authentic capsid assembly in cells infected with structural determinants on the viral particle, but very
poorly with isolated viral polypeptides, it seemed possi-with MVMp wildtype and NS20 mutant viruses. A more
detailed characterization of the sera will be presented in ble that the increased levels of labeled protein precipi-
tated with PN2 after the first chase period might reflecta separate publication (S. F. Cotmore, A. D’Abramo, and
P. Tattersall, manuscript in preparation). The two anti- the process of particle assembly, rather than further syn-
thesis.peptide sera react efficiently and specifically with the
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rather than a defect in the synthesis of capsid proteins
per se.
This finding was confirmed by immunoprecipitating the
extracts with the same anti-allopeptide serum, but now
under native conditions (Fig. 6C). As expected, in both
wildtype and NS2-F86am infections most of the labeled
capsid protein present at the end of the pulse period
could be precipitated with this antibody, indicating that
at this time few capsid proteins were assembled into
normal capsid structures. At later times, however, most of
the capsid proteins from NS2-F86am infections remained
recognizable by the anti-allopeptide serum, whereas
those synthesized during wildtype infection chased into
a form which was not recognized. The NS2-F86am capsid
proteins which were not assembled into particles re-
mained in the cell in their unassembled state for at least
80 min after synthesis (Figs. 6B and 6C, lanes 6 and 9).
However, by 2 hr after synthesis the level of unassembled
protein had begun to decline (Fig. 6C, lane 12), matched
by a concomitant drop in the total capsid protein level
(Fig. 6B, lane 12), without any sign of its gradual conver-
sion into assembled particles (Fig. 6A, lane 12). Thus in
NS20 mutant virus infections any capsid proteins whichFIG. 6. Immunoprecipitation of pulse–chase-labeled viral structural
polypeptides. Autoradiographs of discontinuous SDS–PAGE gels did not assemble into particles soon after synthesis were
showing 35S-labeled capsid proteins (VP1 and VP2) immunoprecipitated retained in the cell for protracted periods in their unfolded
from synchronized A9 cells harvested immediately after a 20-min pulse state. That they did not assemble at a later time suggests
with Tran35S-label initiated 8 hr after release into S-phase (lanes 1–3
either that these proteins became and remained incom-in all panels), or after an additional 40-min chase period in unlabeled
petent for assembly or that a limiting cellular functionmedium (lanes 4–6 in all panels), after an 80-min chase period (lanes
7–9), or after a 2-hr chase period (lanes 10–12). Samples in B were was exhausted.
denatured by heating to 857 for 20 min in 0.375% SDS prior to immuno- Immunofluorescence analysis of synchronized cells
precipitation, while samples in A and C were not heated. Samples in fixed 8 hr after infection and stained with anti-allopeptide
A were immunoprecipitated with rabbit anti-capsid serum, and those
serum revealed that a similar proportion of cells in bothin B and C were precipitated with anti-allopeptide serum. Samples
cultures synthesized capsid polypeptides (Figs. 7A andwere harvested from uninfected synchronized A9 cells (lanes 1, 4, 7,
and 10) or from synchronized cultures infected with either wildtype 7B). When stained with the anti-peptide antibody, in-
MVMp (lanes 2, 5, 8, and 11) or NS2-F86am (lanes 3, 6, 9, and 12). fected cells showed intense cytoplasmic fluorescence,
as expected for newly synthesized, nonassembled cap-
sid proteins. In both populations of infected cells thereTo explore this possibility, we first denatured the sam-
ples by incubating them at 857 for 30 min in 0.375% SDS was equivalent accumulation of signal in the nucleus,
suggesting that capsid polypeptides can be transportedand then precipitated them quantitatively with anti-allo-
peptide serum, which reacts preferentially with isolated into the nucleus prior to assembly. This observation sup-
ports the recent finding that the structural proteins con-proteins. In contrast to the previous result all samples
harvested within 80 min of the pulse were found to con- tain a C-terminal nuclear localization signal, located be-
tween residues 528 and 538 of VP2 (Lombardo et al.,tain approximately equivalent amounts of capsid protein,
when analyzed in this way, irrespective of whether the 1995). The recently determined atomic structure of the
MVM particle (Llamas-Saiz et al., 1997) indicates thatinfecting virus was wildtype or NS2-F86am (Fig. 6B). Thus
in each infection newly synthesized capsid proteins re- these residues would be substantially buried in the intact
capsid, and therefore this signal can probably functionquire a finite time to assemble into particles and become
precipitable with anti-capsid serum, but in the wildtype only prior to assembly.
In marked contrast to the anti-peptide antibody result,infection this process is essentially complete by the end
of the first chase period (i.e., within 40 min). In NS2- staining with PN2 anti-capsid serum revealed correctly
assembled particles concentrated in the nuclei of cellsF86am-infected cells, however, relatively little folding or
assembly occurred during this or subsequent chase peri- infected with wildtype virus, but a greatly diminished level
of nuclear signal in cells infected with the NS2-F86amods, so that most of the labeled protein remained unpre-
cipitable by anti-capsid serum. Thus at 8 hr postinfection mutant virus (compare Figs. 7C and 7D). These observa-
tions are entirely consistent with the metabolic labelingthe defect in capsid synthesis exhibited by NS20 mutant
viruses appeared to reflect a defect in particle assembly and immunoprecipitation studies reported above. The
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FIG. 7. Immunofluorescence staining of viral structural polypeptides. Synchronized A9 cells infected with wildtype MVMp (A and C) or with
NS2-F86am (B and D) were fixed 10 hr after release into S-phase and stained with either anti-allopeptide serum (A and B) or anti-capsid
serum (C and D).
anti-capsid antibody also stains viral antigen within en- tracted and analyzed under nondenaturing conditions,
the diminishing amounts of NS2-F86am capsid proteindosomal vesicles in the cytoplasm in both populations
of infected cells with equivalent intensity. This type of which was synthesized during each of the three pulse
periods continued to be precipitable far more efficientlystaining, which diminishes with time as infection pro-
ceeds, can also be detected in cells which have not been by anti-peptide serum than by anti-capsid serum, while
the reverse was true for the increasingly abundant wild-released from aphidicolin (data not shown), indicating
that it represents residual input virus. type proteins (data not shown).
Total capsid synthesis progressively declines in NS20 DISCUSSION
mutant-infected cells
In this report we detail specific host range-specific
defects in viral replication that result from the prematureSynchronized cells, infected with either wildtype or
NS2-F86am virus, were labeled with [35S]methionine/cys- translational termination or ablation of the viral NS2 poly-
peptides. As reported previously by Naeger and col-teine for 3-hr periods between 6 and 9, 9 and 12, or 12
and 15 hr after release into S-phase. Immunoprecipita- leagues (Naeger et al., 1990), cloned MVMp genomes
encoding truncated forms of the NS2 gene could not betion of fully denatured extracts with anti-allopeptide se-
rum showed that in the wildtype infection the rate of recovered in, and were unable to grow productively in,
their normal murine host cell, but were able to give risecapsid synthesis and accumulation increased as the in-
fection progressed (Fig. 8, lanes 1–3), while in cells in- to progeny virus in the SV40-transformed human fibro-
blast line 324K, albeit with reduced efficiency. The de-fected with the NS20 mutant capsid synthesis was effi-
cient at early times in infection, but became progressively fects in mutant virus growth in these two cell types are
significantly different. In murine cells major lesions inimpaired at later times (Fig. 8, lanes 4–6). Since unas-
sembled capsid proteins had a half-life of approximately both viral DNA replication and capsid assembly were
observed, while the only growth defect found in human2 hr in the previous pulse –chase analysis, it seems prob-
able that this progressive diminution reflects both mark- cells, impaired progeny virus release, was manifested
much later in the life cycle. From this we conclude thatedly reduced synthesis at later times in infection and
slightly elevated rates of protein degradation. When ex- many of the roles played by NS2 in the early replicative
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in progeny export is at present uncertain, it clearly re-
stricts the effective spread of virus through the culture
and provides a rationale for the rapid selection and pref-
erential growth of wildtype revertants that we have ob-
served during stock expansion.
Although we introduced nonsense codons at three dif-
ferent positions in the second exon of NS2, and coupled
one of these with a splice acceptor mutation designed
to prevent the expression of the isolated first exon do-
main, all mutant viruses had the same host range pheno-
type and all failed to show any detectable accumulationFIG. 8. Extended pulse-labeling of viral structural polypeptides. Auto-
of truncated NS2 products. Thus the phenotype we reportradiograph of a discontinuous SDS–PAGE gel showing metabolically
35S-labeled capsid proteins (VP1 and VP2) immunoprecipitated from appears to reflect the absence of NS2, rather than the
denatured extracts of synchronized A9 cells which had been infected stable expression of any particular peptide domain.
with wildtype MVMp (lanes 1– 3) or NS2-F86am (lanes 4–6) and har- Brockhaus et al. (1996) were similarly unable to expressvested immediately after a 3-hr pulse with Tran35S-label spanning the
stable forms of NS2 in murine cells infected with twoperiod from 6 to 9 hr after release into S-phase (lanes 1 and 4), from
mutant MVM viruses which carried mutations near the9 to 12 hr after release (lanes 2 and 5), or from 12 to 15 hr after release
(lanes 3 and 6). Each sample was immunoprecipitated with anti-allo- extreme carboxy-terminus of exon 2 (NS2-2268 and
peptide serum. Df18), although detectable levels of these modified pro-
teins could be produced in a c-Ha-ras-transformed Fisher
rat cell, FREJ4. In a previous study these two particularprocesses of MVM are likely to be indirect, since they
can be complemented by an appropriate cellular environ- mutant viruses had also been shown to express detect-
able levels of NS2 in 324K cells (Naeger et al., 1990),ment. While in agreement with previous analyses
(Naeger et al., 1990, 1993), this finding is remarkable suggesting that the differential stability of mutant NS2
proteins in different cell types might influence host range.given the high-level expression of NS2 early in wildtype
infections, which originally suggested a more direct role However, the viruses used in the present study, as well
as the series of NS2 mutant viruses generated by Naegerfor NS2 in progeny production, perhaps structural or at
least noncatalytic. Possibly such high-level expression et al. (1990) which had termination codons more centrally
located in the body of exon 2, all failed to stably expressis required simply because the virus is unable to express
its genes prior to S-phase and so must reorient the cellu- truncated forms of NS2 in 324K cells (Naeger et al., 1990
and data not shown), and thus it is unlikely that proteinlar replication machinery for viral replication as rapidly
as possible to ensure productive takeover of the cell stability per se is of primary importance. In part, the fail-
ure to accumulate truncated NS2 species likely reflects acycle.
Although NS20 mutant viral stocks could be generated polar shift in the splicing pattern of P4-driven transcripts
reported previously (Naeger et al., 1992), as also sug-in 324K cells, the growth of these viruses was still sub-
stantially impaired relative to that of wildtype MVMp. In gested by the polar shift in NS1 expression seen in the
present study. However, the magnitude of the lesion inconsequence, stocks of all NS20 mutant viruses which
relied upon a single nonsense mutation to inactivate NS2 NS2 synthesis greatly exceeds the reported splicing shift,
suggesting that transcripts encoding the affected genecould be rapidly compromised by the appearance of wild-
type revertants or forward mutants with restored NS2 might be poorly translated or that truncated NS2 polypep-
tides are extremely unstable in vivo.expression. In contrast, mutant NS2-F86am, which car-
ries a complex termination mutation, was unable to revert In both MVM and the closely related parvovirus H1
the inability of NS20 mutants to replicate productively inwith appreciable frequency and so became the virus of
choice in those experiments requiring high-titer pools of rodent cells is associated with a complex series of de-
fects in viral DNA replication (Naeger et al., 1990; Li andNS20 virus. The selective pressure which drives rever-
sion to an NS2/ genotype in 324K cells appears to act Rhode, 1991). Under the conditions used in the present
study duplex DNA replication was reduced to around 5%late in the viral life cycle. While even at late times in a
single-round infection, viral RF DNA replication and cap- of wildtype levels and there was absolutely no evidence
of any single-stranded DNA synthesis. Why NS2 hassid protein synthesis appeared relatively normal, and sin-
gle-stranded progeny synthesis was within twofold of such a critical role in replication remains unknown. Al-
though these observations might suggest that in murinenormal, packaged virions were not efficiently released.
Whether or not there is a nonlytic mechanism for progeny cells it plays a direct role in viral duplex DNA replication,
there is no published in vitro evidence to support thisvirus release from 324K cells remains uncertain, but such
an exocytotic mechanism has been proposed for the premise and we have been unable to substantially influ-
ence NS1-driven in vitro MVM DNA replication in A9early phase of SV40 release from infected cells (Clayson
et al., 1989). While the molecular basis for this late defect extracts by adding wildtype NS2 expressed from recom-
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binant vaccinia constructs (J. P. F. Nuesch, S. F. Cotmore, SDS) to temperatures in excess of 807, conditions which
we considered so stringent that we were prompted toand P. Tattersall, unpublished results). Moreover, an indi-
rect effect mediated through NS1 is also unlikely since reassess whether or not our various anti-intact-capsid
sera could react with similarly dissociated material. Theexpression of NS1 in NS20 mutant infections is some-
what elevated rather than depressed, and replication- anti-allopeptide serum used here is particularly useful
because it reacts quantitatively with monomeric VP1 andcompetent NS1 can be generated in the absence of NS2
in mammalian and insect cells infected with recombinant VP2 molecules released by heating capsids to 807, but
is unable to gain access to the relevant epitopes in thevaccinia or baculovirus vectors (Nuesch et al., 1992;
Christensen et al., 1997). Whether or not NS2 directly great majority of intact, native particles (S. F. Cotmore, A.
D’Abramo, and P. Tattersall, manuscript in preparation).influences progeny single-strand DNA synthesis is more
difficult to evaluate. All single-stranded viral DNA found Using these two types of sera with cell extracts prepared
under native and denaturing conditions at different timesin infected cells is encapsidated, and its synthesis likely
involves direct sequestration of displaced strands into in infection thus allowed us to differentiate between the
processes of capsid protein synthesis and particle as-preformed or partially formed capsids (Cotmore and Tat-
tersall, 1996). Thus the defect in capsid assembly seen sembly in cells infected with mutant MVM genomes.
The observations presented here make it clear thatin NS20 mutant infections would be expected to impinge
severely on single-strand synthesis in its own right, mak- cells infected with wildtype virus assemble capsid parti-
cles far more efficiently than mutant-infected cells anding it impossible to ascertain whether or not NS2 plays
a direct role in the synthesis of progeny strands and/or thus suggest that the virus is able to manipulate the
cellular environment to optimize this process. Nonethe-their encapsidation.
Although our preliminary anti-capsid immunoprecipita- less, in NS2 mutant-infected A9 cells a small number of
the VP proteins synthesized throughout the course of thetions did suggest that capsid protein synthesis might be
defective, this seemed unlikely since NS1 expression infection do assemble into capsid-like structures, al-
though we do not know if they assemble into packaging-appeared relatively normal and the NS1-encoding R1
transcripts contain all of the sequences present in the competent intermediates. Similarly discrete particles can
be produced in cells stably expressing parvoviral capsidcapsid mRNAs. Moreover, transactivation of both a sim-
ple P38 promoter-construct (Doerig et al., 1988) and a genes but lacking the nonstructural gene sequences
(Pintel et al., 1984; Kajigaya et al., 1989) or when theseconstruct in which a CAT-reporter gene initiated at the
VP2 start of otherwise unaltered P38 transcripts (L. F. proteins are expressed in insect cells from recombinant
baculoviruses (Brown et al., 1991; Kajigaya et al., 1991;Carbonell and P. Tattersall, unpublished observations)
had been shown to be dependent on NS1 expression Lopez de Turiso et al., 1992; Martinez et al., 1992; Saliki
et al., 1992; Christensen et al., 1994) and in mammalianbut completely independent of NS2. In a previous study
capsid protein synthesis in NS2 mutant infections was cells from recombinant vaccinia viruses (Clemens et al.,
1992). Some of the VP proteins expressed under thesemeasured by immunoprecipitation of 35S-labeled cell ex-
tracts with anti-capsid serum and related to the level of conditions do assemble into 70S particles carrying a vari-
ety of neutralizing, structure-related antigenic epitopes,P38-driven transcripts in the same infection (Naeger et
al., 1993). Using cell extracts prepared under nondenatur- but most of the expressed proteins do not. Moreover
there is crystallographic evidence to suggest that B19ing conditions, these authors showed a 10-fold defect in
the accumulation of immunoprecipitable VP2 relative to particles assembled in this way may be somewhat disor-
dered (Agbandje et al., 1994). The crystal structure of thetranscript accumulation following a 1-hr pulse 9, 12, or 14
hr after entry into S-phase. Although we initially obtained MVM virion core has recently been determined to atomic
resolution (Llamas-Saiz et al., 1997), but the dispositionsomewhat similar data with our series of mutants, it was
clear that the magnitude of the observed defect de- of the amino-termini of the VP polypeptides remains un-
certain, and as yet we have few reagents available topended on the timing and duration of the labeling period,
so that long pulses late in infection suggested a vastly monitor precise assembly or capsid function.
Since some capsid particles are assembled in mutant-more profound defect than short pulses instituted early
in infection (compare Fig. 8 with Fig. 6A). This led us infected cells, it is unlikely that this process normally
involves a direct interaction between NS2 and the VPto conclude that the capsid defect, whatever its basis,
developed progressively as infection proceeded. polypeptides. Thus, NS2 once again appears to mediate
its effects indirectly by modulating cellular function(s). ASince MVM capsid particles are known to be excep-
tionally rugged, we first used immunoprecipitation with subset of phosphorylated NS2 molecules was recently
shown to bind directly to two members of the highlyanti-VP1-specific serum to explore conditions required
to fully dissociate and denature such particles and thus conserved 14-3-3 family of eukaryotic proteins (Brock-
haus et al., 1996). 14-3-3 molecules have previously beenrender the VP1 proteins fully susceptible to immunopre-
cipitation without coprecipitating VP2. Such dissociation shown to bind to a broad range of cellular and viral
proteins, apparently acting as modulators or ‘‘adaptors’’could only be achieved after heating (with or without
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tions within the capsid are coordinately required for acquisition ofin many critical biochemical activities including signal
fibrotropism by the lymphotropic strain of minute virus of mice. J.transduction, exocytosis, protein transport, and cell cycle
Virol. 66, 3415–3423.
regulation (Freed et al., 1994; Reuther et al., 1994), but Brandenburger, A., Legendre, D., Avalosse, B., and Rommelaere, J.
at present the biological consequences of this interaction (1990). NS-1 and NS-2 proteins may act synergistically in the cyto-
pathogenicity of parvovirus MVMp. Virology 174, 576–584.for MVM are unclear. The middle T antigen of polyoma
Brockhaus, K., Plaza, S., Pintel, D. J., Rommelaere, J., and Salome, N.virus also binds 14-3-3 proteins (Pallas et al., 1994), and
(1996). Nonstructural proteins NS2 of minute virus of mice associatemiddle T is known to induce the activity of so-called
in vivo with 14-3-3 protein family members. J. Virol. 70, 7527–7534.
‘‘permissivity factors’’ in the host cell (Garcea and Benja- Brown, C. S., Van Lent, J. W., Vlak, J. M., and Spaan, W. J. (1991). Assem-
min, 1983; Garcea et al., 1985, 1989). These allow stable bly of empty capsids by using baculovirus recombinants expressing
human parvovirus B19 structural proteins. J. Virol. 65, 2702–2706.phosphorylation of threonine residues in the capsid pro-
Brownstein, D. G., Smith, A. L., Johnson, E. A., Pintel, D. J., Naeger, L. K.,tein VP1 and assembly of mature 240S virions from a
and Tattersall, P. (1992). The pathogenesis of infection with minute75S nucleocapsid intermediate (Garcea et al., 1989), but
virus of mice depends on expression of the small nonstructural pro-
whether there is a causal link between these two activi- tein NS2 and on the genotype of the allotropic determinants VP1
ties is unproven. MVM capsid proteins also show com- and VP2. J. Virol. 66, 3118–3124.
Cater, J. E., and Pintel, D. J. (1992). The small non-structural proteinplex patterns of posttranslational modification (Peterson
NS2 of the autonomous parvovirus minute virus of mice is requiredet al., 1978; Santaren et al., 1993), which might well influ-
for virus growth in murine cells. J. Gen. Virol. 73, 1839–1843.ence the assembly or ultimate structure of the viral parti-
Christensen, J., Alexandersen, S., Bloch, B., Aasted, B., and Uttenthal,
cle, but at present the significance of such processing A. (1994). Production of mink enteritis parvovirus empty capsids by
remains unclear. expression in a baculovirus vector system: A recombinant vaccine
for mink enteritis parvovirus in mink. J. Gen. Virol. 75, 149–155.We conclude that in mouse cells in vivo the absence
Christensen, J., Cotmore, S. F., and P., T. (1997). A novel cellular site-of NS2 down-regulates capsid assembly without initially
specific DNA-binding protein co-operates with the viral NS1 polypep-down-regulating VP synthesis and that, while a lesion in
tide to initiate parvoviral DNA replication. J. Virol. 71, 1405–1416.
VP polypeptide expression does arise late in infection, Clayson, E. T., Brando, L. V., and Compans, R. W. (1989). Release of
this may well be a secondary effect resulting from prod- simian virus 40 virions from epithelial cells is polarized and occurs
without cell lysis. J. Virol. 63, 2278–2288.uct accumulation. A similar progressive drop in capsid
Clemens, D. L., Wolfinbarger, J. B., Mori, S., Berry, B. D., Hayes, S. F.,synthesis at late times in infection was seen in cells
and Bloom, M. E. (1992). Expression of Aleutian mink disease parvov-infected with a group of SV40 host range mutants which
irus capsid proteins by a recombinant vaccinia virus: Self-assembly
carry small deletions in the extreme carboxy-terminal re- of capsid proteins into particles. J. Virol. 66, 3077–3085.
gion of Large T antigen (Spence and Pipas, 1994). Like Clemens, K. E., Cerutis, D. R., Burger, L. R., Yang, C. Q., and Pintel,
D. J. (1990). Cloning of minute virus of mice cDNAs and preliminarythe MVMp NS2 mutants described here, at early times
analysis of individual viral proteins expressed in murine cells. J. Virol.in infection these SV40 host range mutants showed a
64, 3967–3973.defect in virion assembly, but not in capsid protein syn-
Clemens, K. E., and Pintel, D. J. (1988). The two transcription units of
thesis per se. Exactly why this progressive deterioration the autonomous parvovirus minute virus of mice are transcribed in
occurred remains uncertain. In the case of MVM it may a temporal order. J. Virol. 62, 1448–1451.
Cotmore, S. F., and Tattersall, P. (1986). Organization of nonstructuralsimply reflect a progressive drop in the level of accumu-
genes of the autonomous parvovirus minute virus of mice. J. Virol.lated transcripts, as evidenced by the studies of Naeger
58, 724–732.and colleagues (Naeger et al., 1993), but there may also
Cotmore, S. F., and Tattersall, P. (1987). The autonomously replicating
be direct inhibition of the synthetic pathway due to prod- parvoviruses of vertebrates. Adv. Virus Res. 33, 91–174.
uct-mediated negative feedback or the depletion of criti- Cotmore, S. F., and Tattersall, P. (1990). Alternate splicing in a parvoviral
cal cellular components such as chaperone polypep- nonstructural gene links a common amino-terminal sequence to
downstream domains which confer radically different localizationtides. Such progressive defects may thus be symptoms
and turnover characteristics. Virology 177, 477–487.of NS2 gene dysfunction rather than its primary effect.
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